logo logo logo
Ulcerative Colitis

JAK-STAT Pathway

Introduction

JAK-STAT pathway illustration JAK-STAT pathway illustration JAK-STAT pathway illustration
The JAK-STAT pathway plays an important role in the pathogenesis of UC1
 

The JAK-STAT pathway mediates both normal physiological functions and inflammatory responses. 1-3
Emerging research continues to elucidate how the JAK-STAT pathway plays important roles in homeostasis and inflammatory diseases such as UC. 1-3

• Four JAK proteins – JAK1, JAK2, JAK3, and TYK2 – mostly form pairs that mediate cytokine signalling.2,3
• Multiple cytokines bind to their associated receptors to signal through the JAK-STAT pathway.2-4

JAKs in Disease

UC pathogenesis and the JAK-STAT pathway
The JAK-STAT pathway represents a point of convergence common to multiple pathways of inflammation.4,5

JAKs and Cytokines

Each JAK enzyme may have a distinct role to play in cytokine action3,6,7
The four JAK enzymes propagate the signalling of numerous proinflammatory cytokines, including IFN(Ɣ),
IL-2, IL-6, and IL-23.8,9
Four JAK proteins form complexes to facilitate the actions of certain cytokines2,6,9
Key cytokines of the JAK-STAT pathway8,*
Key cytokines of the JAKSTAT pathway infographic Key cytokines of the JAKSTAT pathway infographic Key cytokines of the JAKSTAT pathway infographic
JAK protein complexes form specific JAK-STAT pathways that play a unique role in normal physiological 
functions. 9,10,16
 


* Not all cytokines are included in this graphic.

Related

Inflammatory Pathways

Learn more about inflammation in UC.

PREVIOUS
JAK Pairings

Learn more about the roles of different JAK pairs.

NEXT
JAK Pairings JAK Pairings JAK Pairings
EPO, erythropoietin; GM-CSF, granulocyte-macrophage colony-stimulating factor; IBD, inflammatory bowel disease; IFN, interferon; IL, interleukin; JAK, Janus kinase; NK, natural killer; STAT, signal transducer and activator of transcription; TPO, thrombopoietin; TYK, tyrosine kinase; UC, ulcerative colitis.
REFERENCES: 1.Coskun M, Salem M, Pedersen J, Nielsen OH. Pharmacol Res. 2013;76:1-8. 2. O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. Annu Rev Med. 2015;66:311-328. 3. Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O'Shea JJ. Nat Rev Drug Discov. 2017;16(12):843-862. 4. Fernández-Clotet A, Castro-Poceiro J, Panés J. Curr Pharm Des. 2019;25(1):32-40. 5. Salas A, Hernandez-Rocha C, Duijvestein M, et al. Nat Rev Gastroenterol Hepatol. 2020;17(6):323-337. 6. Choy EH. Rheumatology (Oxford). 2019;58(6):953-962. 7. Gadina M, Johnson C, Schwartz D. J Leukoc Biol. 2018;104(3):499-514. 8. Winthrop KL. Nat Rev Rheumatol. 2017;13(4):234-243. 9. Clark JD, Flanagan ME, Telliez JB. J Med Chem. 2014;57(12):5023-5038. 10. Ghoreschi K, Laurence A, O'Shea JJ. Immunol Rev. 2009;228(1):273-287. 11. Wu Y, Tian Z, Wei H. Front Immunol. 2017;8:930. 12. Maeda K, Malykhin A, Teague-Weber BN, Sun XH, Farris AD, Coggeshall KM. Blood. 2009;113(19):4534-4540. 13. Morris R, Kershaw NJ, Babon J. Protein Sci. 2018;(27):1984-2009. 14. Tang Y, Liu W, Wang W, et al. Cardiovasc Drugs Ther. 2020;34(2):145-152. 15. Takaoka A, Yanai H. Cell Microbiol. 2006;8(6):907-922. 16. Gadina M, Le MT, Schwartz DM. Rheumatology (Oxford). 2019;58(Suppl 1):i4-i16. 
galapagos-health galapagos-health galapagos-health


GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos
NV.
© 2021 Galapagos NV. All rights reserved.

GL-UC-FIL-202105-00003 08/21

Popular Pages
Other Categories
Follow us here too
galapagos-health galapagos-health galapagos-health


GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos
NV.
© 2021 Galapagos NV. All rights reserved.

GL-UC-FIL-202105-00003 08/21

Privacy notice
Cookie policy
Terms of use
Site map
Disclaimer

© Copyright 2021 Galapagos NV